Yes,
to Clarify these are the numbers
11,000 transplants completed annually, along with baseline immunosuppresants administered.
5,500 of those ( about 50% ), develop aGvHD, with around 1200 being children.
First line approved treatment
Adults recieve "optimised" - ( More ) steroids and immunosupressants.
Children have nothing approved, but may get the same as the adults seeing as nothing is approved.
Second line treatments
Adults recieve anything ( these are not approved either ) , there is not " standard" second line. It could be MSC, different steroids, green tea, Reg's poems, anything.
After completeing the first / second line treatment lines approximately 600 children, and 3000 adults remain as non responders. ( Nothing has worked ).
These are in my opinion the most needy candidates for off label, as without some treatment that works - death will occur.
That would equate to around 2 Billion USD in sales if all 3600 were treated with the pricing assumptions of 400,000 child, 600,000 adult.
- Forums
- ASX - By Stock
- MSB
- 2024 Here we go again.
2024 Here we go again., page-523
-
- There are more pages in this discussion • 421 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B |
Open | High | Low | Value | Volume |
$1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | $1.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.46 | 27045 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | 1.450 |
1 | 2574 | 1.440 |
1 | 15000 | 1.435 |
2 | 11400 | 1.430 |
1 | 15000 | 1.425 |
Price($) | Vol. | No. |
---|---|---|
1.455 | 14000 | 1 |
1.460 | 14000 | 1 |
1.465 | 14000 | 1 |
1.480 | 50134 | 1 |
1.485 | 40331 | 2 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |